298 related articles for article (PubMed ID: 28939767)
1. Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding.
Challasivakanaka S; Zhen J; Smith ME; Reith MEA; Foster JD; Vaughan RA
J Biol Chem; 2017 Nov; 292(46):19066-19075. PubMed ID: 28939767
[TBL] [Abstract][Full Text] [Related]
2. Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms.
Cervinski MA; Foster JD; Vaughan RA
J Biol Chem; 2005 Dec; 280(49):40442-9. PubMed ID: 16204245
[TBL] [Abstract][Full Text] [Related]
3. Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.
Foster JD; Yang JW; Moritz AE; Challasivakanaka S; Smith MA; Holy M; Wilebski K; Sitte HH; Vaughan RA
J Biol Chem; 2012 Aug; 287(35):29702-12. PubMed ID: 22722938
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
Goodwin JS; Larson GA; Swant J; Sen N; Javitch JA; Zahniser NR; De Felice LJ; Khoshbouei H
J Biol Chem; 2009 Jan; 284(5):2978-2989. PubMed ID: 19047053
[TBL] [Abstract][Full Text] [Related]
5. Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.
Calipari ES; Ferris MJ; Siciliano CA; Jones SR
ACS Chem Neurosci; 2015 Jan; 6(1):155-62. PubMed ID: 25474655
[TBL] [Abstract][Full Text] [Related]
6. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
[TBL] [Abstract][Full Text] [Related]
7. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
Sandoval V; Riddle EL; Ugarte YV; Hanson GR; Fleckenstein AE
J Neurosci; 2001 Feb; 21(4):1413-9. PubMed ID: 11160413
[TBL] [Abstract][Full Text] [Related]
9. Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens.
Richards TL; Zahniser NR
J Neurochem; 2009 Mar; 108(6):1575-84. PubMed ID: 19183252
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
Moritz AE; Foster JD; Gorentla BK; Mazei-Robison MS; Yang JW; Sitte HH; Blakely RD; Vaughan RA
J Biol Chem; 2013 Jan; 288(1):20-32. PubMed ID: 23161550
[TBL] [Abstract][Full Text] [Related]
11. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
[TBL] [Abstract][Full Text] [Related]
12. Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.
German CL; Hanson GR; Fleckenstein AE
J Neurochem; 2012 Oct; 123(2):288-97. PubMed ID: 22804716
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
Kahlig KM; Javitch JA; Galli A
J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
[TBL] [Abstract][Full Text] [Related]
14. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
15. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
[TBL] [Abstract][Full Text] [Related]
16. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen Directly Interacts with the Dopamine Transporter.
Mikelman SR; Guptaroy B; Schmitt KC; Jones KT; Zhen J; Reith MEA; Gnegy ME
J Pharmacol Exp Ther; 2018 Oct; 367(1):119-128. PubMed ID: 30108161
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
Boudanova E; Navaroli DM; Melikian HE
Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
[TBL] [Abstract][Full Text] [Related]
19. The dopamine transporter carboxyl-terminal tail. Truncation/substitution mutants selectively confer high affinity dopamine uptake while attenuating recognition of the ligand binding domain.
Lee FJ; Pristupa ZB; Ciliax BJ; Levey AI; Niznik HB
J Biol Chem; 1996 Aug; 271(34):20885-94. PubMed ID: 8702845
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
